Bococizumab is a cutting-edge anti-PCSK9 antibody specifically developed to address hypercholesterolemia. It therapeutic agent works by the PCSK9 protein, a critical regulator of cholesterol amounts. By neutralizing https://lulurmtc543225.mpeblog.com/73174427/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia